We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
10 Year Est. Return
AUM
$6.84M
AUM Growth
+$13.2K
Cap. Flow
-$112K
Cap. Flow %
-1.64%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$112K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKUR
1
OnKure Therapeutics
OKUR
$155M
$4.31M 63%
253,422
SPRB
2
Spruce Biosciences
SPRB
$182M
$1.39M 20.39%
39,150
XLO icon
3
Xilio Therapeutics
XLO
$59.3M
$1.14M 16.6%
102,960
VAPO
4
DELISTED
Vapotherm, Inc. Common Stock
VAPO
-52,881
Closed -$112K

Similar funds

RiverVest Venture Management's Q3 2024 Portfolio in Review

As of Q3 2024, RiverVest Venture Management held 4 positions worth $6.84M, up 0.19% from $6.82M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RiverVest Venture Management's Q3 2024 filing shows 1 closed position. The largest sale was Vapotherm, Inc. Common Stock, an estimated $112K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management fully exited Vapotherm, Inc. Common Stock in Q3 2024, selling an estimated $112K.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $6.84M portfolio in Q3 2024.
  • RiverVest Venture Management opened 0 new positions and closed 1 in Q3 2024.
  • RiverVest Venture Management's portfolio value rose 0.19% quarter-over-quarter to $6.84M.

Based on RiverVest Venture Management's 13F filing for Q3 2024, filed 30 Oct 2024.